VANCOUVER, April 7 /PRNewswire-FirstCall/ - EnWave Corporation (TSX-V: ENW) ("EnWave" or "the Company") today announced the successful completion of tests using its recently developed powderREV technology in the dehydration of cultures and probiotics from the Danish group Danisco. The tests were conducted as the first phase of an Agreement signed with Danisco last year. The objective of the agreement is to create a dehydration method delivering high-speed continuous bulk powder processing capable of handling sensitive biological materials, such as cultures.
powderREV is a new Radiant Energy Vacuum (REV) process designed to convert a liquid stream of biological materials into bulk powder on a continuous basis. Preliminary tests on cultures were conducted at EnWave's Vancouver lab using the single-vial REV prototype. Post-dehydration bioactivity levels from the REV dehydration methods show that REV-dried cultures are capable of achieving equivalent, or possibly better bioactivity for certain cultures than freeze-dried samples.
Based on the success of these early results, EnWave and Danisco will now undertake the second phase of the Agreement to evaluate the commercial viability of EnWave's powderREV dehydration technology on a wider scope. The terms of the Agreement grant Danisco with exclusivity for a limited period of time. EnWave and Danisco expect this second phase to be completed in the 2nd quarter of 2010.
"We are excited by the opportunity to test our new powderREV technology with a leading global player in the food culture industry," said Dr. Tim Durance chairman and Co-CEO of EnWave. "We intend to build on the success of the phase one tests and look forward to exploring future collaboration opportunities with Danisco".
With 7,200 employees operating from more than 80 locations in the world, Danisco reported annual revenues of 18.7 billion DKK (US$3.1 billion) in its 2007/2008 year end results. The Danish group is a globa
|SOURCE EnWave Corporation|
Copyright©2009 PR Newswire.
All rights reserved